Brentuximab Vedotin in the Elderly Hodgkin Lymphoma Patients at First Relapse or With Primary Refractory Disease.
Clinical trial NCT02227433 · COMPLETED
Trial details
- NCT number
- NCT02227433
- Sponsor
- Fondazione Italiana Linfomi - ETS
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-04
- Primary completion
- 2018-04-03
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.